GNH USA

Europe — EMA

Minirin (Desmopressin Acetate Trihydrate)

GNH USA supplies Minirin (Desmopressin), a vasopressin analog for central diabetes insipidus, nocturnal enuresis and bleeding disorders.

Desmopressin Acetate Trihydrate

Request sourcing

1
Pack/s

What is Desmopressin Acetate Trihydrate?

Desmopressin, the active ingredient in Minirin, is a vasopressin analog presented as an injection solution for intramuscular, intravenous, or subcutaneous use. It treats central diabetes insipidus, nocturnal enuresis, and certain bleeding disorders in appropriate patients.

GNH USA supplies Minirin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Desmopressin Acetate Trihydrate used for?

Desmopressin is a synthetic vasopressin analog that acts on renal V2 receptors to reduce urine output and promote hemostasis.

- Central diabetes insipidus: reduces excessive urine production and helps maintain water balance. - Nocturnal enuresis: decreases nighttime bedwetting episodes in children and adolescents. - Hemophilia A and von Willebrand disease: raises plasma factor VIII and von Willebrand factor levels to improve clotting.

What are the side effects of Desmopressin Acetate Trihydrate?

Desmopressin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Hyponatremia: low blood sodium levels, often mild. - Headache: transient and usually resolves without intervention. - Nausea: occasional gastrointestinal upset. - Abdominal cramps: mild discomfort in the stomach area. - Facial flushing: temporary reddening of the skin. - Mild hypotension: slight drop in blood pressure.

Serious or Rare Side Effects: - Severe hyponatremia: can lead to seizures or coma. - Water intoxication: excessive fluid retention causing cerebral edema. - Allergic reactions: rash, itching, or anaphylaxis in rare cases. - Thrombotic events: rare clot formation linked to elevated factor VIII. - Severe hypotension: marked drop in blood pressure requiring medical attention. - Pulmonary edema: fluid accumulation in the lungs, extremely uncommon.

What precautions apply to Desmopressin Acetate Trihydrate?

Before using Minirin, consider the following safety measures.

- Monitor serum sodium: check sodium levels regularly, especially in high‑risk patients. - Renal impairment: adjust use in patients with reduced kidney function. - Hypertension: avoid in uncontrolled high blood pressure. - Elderly patients: start with lower doses and monitor closely. - Hypersensitivity: discontinue if allergic reactions occur. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Desmopressin Acetate Trihydrate interact with?

Desmopressin can interact with several medicines; awareness helps prevent complications.

Major Interactions (Avoid): - Carbamazepine: increases desmopressin clearance, reducing efficacy. - Loop or thiazide diuretics: heighten risk of hyponatremia. - NSAIDs: may impair renal handling of water, worsening hyponatremia.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: additive effect on sodium balance. - SSRIs or other serotonergic agents: increase risk of low sodium levels. - Anticoagulants: monitor clotting parameters when used for bleeding disorders.

Frequently asked questions

What conditions is Minirin used to treat?+
Minirin, containing desmopressin, is prescribed for central diabetes insipidus to control excessive urination, for nocturnal enuresis to reduce nighttime bedwetting in children and adolescents, and for certain bleeding disorders such as mild hemophilia A and von Willebrand disease to improve clotting factor levels.
How does desmopressin work in the body?+
Desmopressin is a synthetic analogue of vasopressin that selectively activates V2 receptors in the kidney’s collecting ducts. This activation raises cyclic AMP, prompting aquaporin‑2 channels to move to the cell surface, which increases water reabsorption and concentrates urine. It also stimulates release of von Willebrand factor and factor VIII from endothelial cells, aiding haemostasis.
What is the usual dose of Minirin?+
The appropriate dose of Minirin is determined by a qualified prescriber based on the patient’s specific condition, age, weight, renal function, and response to therapy. Dosage forms include injectable solutions administered intramuscularly, intravenously, or subcutaneously, and the prescribing clinician will set the exact regimen.
Is Minirin safe to use during pregnancy or breastfeeding?+
Safety data for Minirin in pregnancy and lactation are limited, and the product is classified as a category where benefits must be weighed against potential risks. Healthcare providers should evaluate the necessity of treatment and discuss possible effects with the patient before prescribing during pregnancy or while breastfeeding.
How do I order Minirin from GNH USA?+
To request Minirin, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details (including cold‑chain handling if needed) and necessary import documentation.
How does Minirin compare with other antidiuretic agents?+
Minirin (desmopressin) is a selective V2‑receptor agonist, offering a longer duration of action and fewer vasoconstrictive effects compared with natural vasopressin (ADH). Unlike non‑selective analogues, desmopressin has minimal impact on blood pressure, making it preferable for patients where cardiovascular stability is a concern.
What are the storage requirements for Minirin?+
Minirin should be stored at 2‑8 °C in a refrigerator. Keep the vial in its original packaging, protect it from light, and avoid freezing or shaking the solution. If temporary temperature excursions occur, consult the product’s stability guidelines before use.
How is Minirin administered to patients?+
Minirin is supplied as an injectable solution and can be given intramuscularly, intravenously, or subcutaneously, depending on the clinical indication and prescriber’s preference. Administration technique follows standard aseptic injection practices, and dosing intervals are individualized by the treating physician.
What are the most serious risks associated with Minirin?+
The most serious risks include severe hyponatremia leading to seizures or coma, water intoxication with cerebral edema, and rare allergic reactions such as anaphylaxis. Patients should be monitored for signs of low sodium, rapid weight gain, or neurological changes, and treatment should be stopped if serious adverse events occur.
Who should not use Minirin?+
Minirin is contraindicated in patients with known hypersensitivity to desmopressin or any excipients, in those with uncontrolled hypertension, and in individuals with severe renal impairment where fluid balance cannot be safely managed. It should also be avoided in patients with chronic hyponatremia or conditions predisposing to water retention.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Desmopressin Acetate Trihydrate
Route
Intramuscular Use , Intravenous Use , Subcutaneous
Manufacturer
Ferring S.A.S.
Origin
EU

Related products

Desmogalen

Desmogalen

Desmopressin Acetate Trihydrate

Galenpharma Gmbh
EU
Desmopressin Acetate Aspire Pharma

Desmopressin Acetate Aspire Pharma

Desmopressin Acetate Trihydrate

Aspire Pharma Limited
EU
Desmopressin Acetate Mylan

Desmopressin Acetate Mylan

Desmopressin Acetate Trihydrate

Mylan B.V.
EU
Desmopressin Aspire Pharma

Desmopressin Aspire Pharma

Desmopressin Acetate Trihydrate

Aspire Pharma Limited
EU